PlainRecalls
FDA Food Moderate Class II Terminated

PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802

Reported: September 3, 2014 Initiated: June 20, 2013 #F-2400-2014

Product Description

PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802

Reason for Recall

The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.

Details

Recalling Firm
Beta Labs
Units Affected
743 units
Distribution
nationwide and UK
Location
Memphis, TN

Frequently Asked Questions

What product was recalled?
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802. Recalled by Beta Labs. Units affected: 743 units.
Why was this product recalled?
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Which agency issued this recall?
This recall was issued by the FDA Food on September 3, 2014. Severity: Moderate. Recall number: F-2400-2014.